01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

cells by chCE7 antibody-mediated gene transfer. Gene Ther
4, 156-161.
Conary JT, Parker RE, Christman BW, Raulks RD, King GA,
Meyrick BO, Brigham KL (1994) Protection of rabbit lungs
from endotoxin injury by in vivo hyperexpression of the
prostaglandin G/H synthase gene. J Clin Invest 93, 1834-
1840.
Connelly S and Kaleko M (1998) Hemophilia A: current
treatment and future gene therapy. Gene Ther Mol Biol 1,
279-292.
Conrad CK, Allen SS, Afione SA, Reynolds TC, Beck SE, Fee-
Maki M, Barrazza-Ortiz X, Adams R, Askin FB, Carter BJ,
Guggino WB, Flotte TR (1996) Safety of single-dose
administration of an adeno-associated virus (AAV)-CFTR
vector in the primate lung. Gene Ther 3, 658-668.
Considine RV, Considine EL, Williams CJ, Nyce MR, Magosin
SA, Bauer TL, Rosato EL, Colberg J, Caro JF (1995)
Evidence against either a premature stop codon or the
absence of obese gene mRNA in human obesity. J Clin
Invest 95, 2986-2988.
Cooney M, Czernuszewicz G, Postel EH, Flint SJ, Hogan ME
(1988) Site-specific oligonucleotide binding represses
transcription of the human c-myc gene in vitro. Science 241,
456-459.
Corbeau P, Kraus G, and Wong-Staal F (1996) Efficient gene
transfer by a human immunodeficiency virus type 1 (HIV-1)derived
vector utilizing a stable HIV packaging cell line.
Proc Natl Acad Sci USA 93, 14070-14075.
Corey CA, Desilva AD, Holland CA, and Williams DA (1990)
Serial transplantation of MTX resistant bone marrow;
protection of murine recipients from drug toxicity by
progeny of transduced stem cells. Blood 76, 337-343.
Cornetta K and Anderson WF (1989) Protamine sulfate as an
effective alternative to polybrene in retroviral-mediated
gene-transfer: implications for human gene therapy. J Virol
Methods 23, 187-194.
Cotten M, Wagner E, Zatloukal K, Phillips S, Curiel DT, and
Birnstiel ML (1992) High efficiency receptor-mediated
delivery of small and large (48 kilobase) gene constructs
using the endosome disruption activity of defective or
chemically inactivated adenovirus particles. Proc Natl Acad
Sci USA 89, 6094-6098.
Cox LS, Hupp T, Midgley CA, Lane DP (1995) A direct effect
of activated human p53 on nuclear DNA replication. EMBO
J 14, 2099-2105.
Crook K, McLachlan G, Stevenson BJ, Porteous DJ (1997)
Plasmid DNA molecules complexed with cationic liposomes
are protected from degradation by nucleases and shearing by
aerosolisation. Gene Ther 3, 834-839.
Cross GAM (1987) Eukaryotic protein modification and
membrane attachment via phosphatidylinositol. Cell 48, 179-
181.
Crystal RG (1990) α1-antitrypsin deficiency, emphysema, and
liver disease. J Clin Invest 85, 1343-1352.
Cuevas P, Garcia-Calvo M, Carceller F, Reimers D, Zazo M,
Cuevas B, Munoz-Willery I, Martinez-Coso V, Lamas S,
Gimenez-Gallego G (1996) Correction of hypertension by
normalization of endothelial levels of fibroblast growth
Boulikas: An overview on gene therapy
136
factor and nitric oxide synthase in spontaneously
hypertensive rats. Proc Natl Acad Sci USA 93, 11996-
12001.
Culver KW (1996) in “Gene Therapy: a primer for
physicians”. Second Edition. Mary Ann Liebert, Inc.
Publications NY. pp. 1-198.
Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, and
Blaese RM (1992) In vivo gene transfer with retroviral
vector-producer cells for treatment of experimental brain
tumors. Science 256, 1550-1552.
Curiel DT (1994) High-efficiency gene transfer employing
adenovirus-polylysine-DNA complexes. Nat Immun 13,
141-164.
Curiel DT, Agarwal S, Wagner E, and Cotten M (1991)
Adenovirus enhancement of transferrrin-polylysine-mediated
gene delivery. Proc Natl Acad Sci USA 88, 8850-8854.
Cwirla SE, Peters EA, Barrett RW, and Dower WJ (1990)
Peptides on phage: a vast library of peptides for identifying
ligands. Proc Natl Acad Sci USA 87, 6378-6382.
Czubayko F, Downing SG, Hsieh SS, Goldstein DJ, Lu PY,
Trapnell BC, and Wellstein A (1997) Adenovirus-mediated
transduction of ribozymes abrogates HER-2/neu and
pleiotrophin expression and inhibits tumor cell proliferaation.
Gene Ther 4, 934-949.
D’Souza MP and Harden VA (1996) Chemokines and HIV-1
second receptors. Confluence of two fields generates
optimism in aids research. Nat Med 2, 1293-1300.
da Costa LT, Jen J, He T-C, Chan TA, Kinzler KW, and
Vogelstein B (1996) Converting cancer genes into killer
genes. Proc Natl Acad Sci USA 93, 4192-4196.
Dai Y, Roman M, Naviaux RK, and Verma IM (1992) Gene
therapy via primary myoblasts: Long term expression of
factor IX protein following transplantation in vivo. Proc
Natl Acad Sci USA 89, 10892-10895.
Dai Y, Schwarz EM, Gu D, Zhang W-W, Sarvetnick N, and
Verma IM (1995) Cellular and humoral immune responses to
adenoviral vectors containing factor IX gene: Tolerization of
factor IX and vector antigens allows for long-term
expression. Proc Natl Acad Sci USA 92, 1401-1405.
Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994)
Control of angiogenesis in fibroblasts by p53 regulation of
thrombospondin-1. Science 265, 1582-1584.
Das Gupta TK, Cohen EP, Richards JM (1997) Phase I
evaluation of interleukin-2-transfected irradiated allogeneic
melanoma for the treatment of metastatic melanoma:
appendix 1: protocol. Hum Gene Ther 8, 1701-1714.
Davies JC, Stern M, Dewar A, Caplen NJ, Munkonge FM, Pitt T,
Sorgi F, Huang L, Bush A, Geddes DM, Alton EW (1997)
CFTR gene transfer reduces the binding of Pseudomonas
aeruginosa to cystic fibrosis respiratory epithelium. Am J
Respir Cell Mol Biol 16, 657-663.
Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain
V, Ryan TE, Bruno J, RadziejewskiC, Maisonpierre PC, and
Yancopoulos GD (1996) Isolation of angiopoietin-1, a ligand
for the TIE2 receptor, by secretion-trap expression cloning.
Cell 87, 1161-1169.